Citius Pharmaceuticals (CTXR) Non Operating Interest Expenses (2010 - 2026)
Citius Pharmaceuticals (CTXR) reported Non Operating Interest Expenses of $231,732 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 34.5% from $172,262 a year earlier and up 601.6% from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Citius Pharmaceuticals' Non Operating Interest Expenses came in at $515,821, up 188.0% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $267,782.
- Non Operating Interest Expenses has a five-year compound annual growth rate of 76.4% (FY2020 to FY2025).
- By fiscal year, Non Operating Interest Expenses came in at $10,839 in FY2021 (-30.8%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Non Operating Interest Expenses since fiscal Q4 2017.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $33,031 (Q2 2026), $155,538 (Q1 2026) and $95,520 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Citius Pharmaceuticals | 14.55 Mn | 23.85 Mn | 1.00 Mn | 231,732.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 231,732.00 |
| Mar 31, 2026 | 33,031.00 |
| Dec 31, 2025 | 155,538.00 |
| Sep 30, 2025 | 95,520.00 |
| Jun 30, 2025 | 172,262.00 |
| Jun 30, 2021 | 2,932.00 |
| Mar 31, 2021 | 3,939.00 |
| Dec 31, 2020 | 3,968.00 |
| Sep 30, 2020 | 3,457.00 |
| Jun 30, 2020 | 4,245.00 |
| Mar 31, 2020 | 3,980.00 |
| Dec 31, 2019 | 3,991.00 |
| Sep 30, 2019 | 4,197.00 |
| Jun 30, 2019 | 4,138.00 |
| Mar 31, 2019 | 4,105.00 |
| Dec 31, 2018 | 4,003.00 |
| Sep 30, 2018 | 3,848.00 |
| Jun 30, 2018 | 3,900.00 |
| Mar 31, 2018 | 4,706.00 |
| Dec 31, 2017 | 3,384.00 |
API Access
Citius Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();